Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
Int J Clin Oncol
2011 Aug 01;164:287-93. doi: 10.1007/s10147-010-0160-8.
Show Gene links
Show Anatomy links
Non-small cell lung cancer in never smokers as a representative 'non-smoking-associated lung cancer': epidemiology and clinical features.
Yano T
,
Haro A
,
Shikada Y
,
Maruyama R
,
Maehara Y
.
Abstract
Recent interest in lung cancer without a history of tobacco smoking has led to the classification of a distinct disease entity of 'non-smoking-associated lung cancer'. In this review article, we have made an overview of the recent literature concerning both the epidemiology and clinical features of lung cancer in never smokers, and have brought 'non-smoking-associated lung cancer' into relief. The etiology of lung cancer in never smokers remains indefinite although many putative risk factors have been described including secondhand smoking, occupational exposures, pre-existing lung diseases, diet, estrogen exposure, etc. Non-small cell lung cancer (NSCLC) in never smokers is clinically characterized by an increased incidence in females and a higher occurrence of adenocarcinoma in comparison to NSCLC in ever smokers in both surgical patients and non-resectable advanced-stage patients. Furthermore, the prognosis of never-smoking NSCLC is better than that of smoking-related NSCLC in both surgical patients and non-resectable advanced-stage patients. Recently recognized novel gene mutations such as EGFR (epidermal growth factor receptor) mutations are largely limited to never smokers or light smokers, and the expression of this gene is responsible for the clinical efficacy of gefitinib, an epidermal growth factor receptor-tyrosine kinase inhibitor. NSCLC with the EML4 (echinoderm microtubule-associated protein-like 4)-ALK (anaplastic lymphoma kinase) fusion gene is also more likely to occur in never smokers and in those with adenocarcinoma histology, and is expected to benefit from ALK inhibitors. In consideration of the future increase in never-smoking NSCLC or 'non-smoking-associated lung cancer', both clinical trials and investigations are needed.
Bai,
Epidermal growth factor receptor mutations in plasma DNA samples predict tumor response in Chinese patients with stages IIIB to IV non-small-cell lung cancer.
2009, Pubmed
Bai,
Epidermal growth factor receptor mutations in plasma DNA samples predict tumor response in Chinese patients with stages IIIB to IV non-small-cell lung cancer.
2009,
Pubmed
Bernstein,
High breast cancer incidence rates among California teachers: results from the California Teachers Study (United States).
2002,
Pubmed
Boffetta,
Incidence of lung cancer in a large cohort of non-smoking men from Sweden.
2001,
Pubmed
Brennan,
Secondhand smoke exposure in adulthood and risk of lung cancer among never smokers: a pooled analysis of two large studies.
2004,
Pubmed
Brenner,
Lung cancer risk in never-smokers: a population-based case-control study of epidemiologic risk factors.
2010,
Pubmed
Brownson,
Epidemiology and prevention of lung cancer in nonsmokers.
1998,
Pubmed
Colditz,
The Nurses' Health Study: 20-year contribution to the understanding of health among women.
1997,
Pubmed
Cross,
A prospective study of red and processed meat intake in relation to cancer risk.
2007,
Pubmed
Etzel,
Risk for smoking-related cancer among relatives of lung cancer patients.
2003,
Pubmed
Ferguson,
Sex-associated differences in survival of patients undergoing resection for lung cancer.
2000,
Pubmed
Freedman,
Cigarette smoking and subsequent risk of lung cancer in men and women: analysis of a prospective cohort study.
2008,
Pubmed
Fu,
Lung cancer in women: analysis of the national Surveillance, Epidemiology, and End Results database.
2005,
Pubmed
Fujisawa,
Smoking before surgery predicts poor long-term survival in patients with stage I non-small-cell lung carcinomas.
1999,
Pubmed
Haiman,
Ethnic and racial differences in the smoking-related risk of lung cancer.
2006,
Pubmed
Hanagiri,
Significance of Smoking as a Postoperative Prognostic Factor in Patients with Non-small Cell Lung Cancer.
2008,
Pubmed
Huang,
Iron overload and its association with cancer risk in humans: evidence for iron as a carcinogenic metal.
2003,
Pubmed
Jackman,
Impact of epidermal growth factor receptor and KRAS mutations on clinical outcomes in previously untreated non-small cell lung cancer patients: results of an online tumor registry of clinical trials.
2009,
Pubmed
Kawaguchi,
Gender, histology, and time of diagnosis are important factors for prognosis: analysis of 1499 never-smokers with advanced non-small cell lung cancer in Japan.
2010,
Pubmed
Kohno,
Association of CYP19A1 polymorphisms with risks for atypical adenomatous hyperplasia and bronchioloalveolar carcinoma in the lungs.
2010,
Pubmed
Koivunen,
EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer.
2008,
Pubmed
Kolonel,
A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics.
2000,
Pubmed
Koo,
Worldwide epidemiological patterns of lung cancer in nonsmokers.
1990,
Pubmed
Kosaka,
Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications.
2004,
Pubmed
Kuiper,
Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta.
1998,
Pubmed
Kurahashi,
Passive smoking and lung cancer in Japanese non-smoking women: a prospective study.
2008,
Pubmed
Kwak,
Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.
2010,
Pubmed
Lee,
Impact of environmental tobacco smoke on the incidence of mutations in epidermal growth factor receptor gene in never-smoker patients with non-small-cell lung cancer.
2010,
Pubmed
Liang,
Facts and fiction of the relationship between preexisting tuberculosis and lung cancer risk: a systematic review.
2009,
Pubmed
Lorenzo Bermejo,
Familial lung cancer and aggregation of smoking habits: a simulation of the effect of shared environmental factors on the familial risk of cancer.
2005,
Pubmed
Lynch,
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib.
2004,
Pubmed
Matakidou,
Case-control study of familial lung cancer risks in UK women.
2005,
Pubmed
McCord,
Iron, free radicals, and oxidative injury.
1998,
Pubmed
Mirvish,
N-nitroso compounds: their chemical and in vivo formation and possible importance as environmental carcinogens.
1977,
Pubmed
Mitsudomi,
Longer survival after resection of non-small cell lung cancer in Japanese women.
1989,
Pubmed
Nitadori,
Association between lung cancer incidence and family history of lung cancer: data from a large-scale population-based cohort study, the JPHC study.
2006,
Pubmed
Nordquist,
Improved survival in never-smokers vs current smokers with primary adenocarcinoma of the lung.
2004,
Pubmed
Nose,
Association between estrogen receptor-beta expression and epidermal growth factor receptor mutation in the postoperative prognosis of adenocarcinoma of the lung.
2009,
Pubmed
Ohgaki,
Carcinogenicities of heterocyclic amines in cooked food.
1991,
Pubmed
Okasaka,
hOGG1 Ser326Cys polymorphism and risk of lung cancer by histological type.
2009,
Pubmed
Paez,
EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.
2004,
Pubmed
Pao,
EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib.
2004,
Pubmed
Park,
Adenocarcinoma of lung in never smoked children.
2008,
Pubmed
Pham,
Use of cigarette-smoking history to estimate the likelihood of mutations in epidermal growth factor receptor gene exons 19 and 21 in lung adenocarcinomas.
2006,
Pubmed
Raso,
Immunohistochemical expression of estrogen and progesterone receptors identifies a subset of NSCLCs and correlates with EGFR mutation.
2009,
Pubmed
Reinik,
Polycyclic aromatic hydrocarbons (PAHs) in meat products and estimated PAH intake by children and the general population in Estonia.
2007,
Pubmed
Rimm,
Effectiveness of various mailing strategies among nonrespondents in a prospective cohort study.
1990,
Pubmed
Rosell,
Screening for epidermal growth factor receptor mutations in lung cancer.
2009,
Pubmed
Sardari Nia,
Prognostic value of smoking status in operated non-small cell lung cancer.
2005,
Pubmed
Satouchi,
Predictive factors associated with prolonged survival in patients with advanced non-small-cell lung cancer (NSCLC) treated with gefitinib.
2007,
Pubmed
Scagliotti,
Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer.
2008,
Pubmed
Sekine,
Risk quantification for pulmonary complications after lung cancer surgery.
2010,
Pubmed
Seow,
Reproductive variables, soy intake, and lung cancer risk among nonsmoking women in the Singapore Chinese Health Study.
2009,
Pubmed
Shaw,
Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK.
2009,
Pubmed
Shih,
A polymorphism in the hMLH1 gene (-93G-->A) associated with lung cancer susceptibility and prognosis.
2010,
Pubmed
Shimazu,
Isoflavone intake and risk of lung cancer: a prospective cohort study in Japan.
2010,
Pubmed
Sioris,
Survival in operable non-small-cell lung cancer: role of p53 mutations, tobacco smoking and asbestos exposure.
2000,
Pubmed
Soda,
Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer.
2007,
Pubmed
,
Echinobase
Stabile,
Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor alpha and beta and show biological responses to estrogen.
2002,
Pubmed
Subramanian,
Presentation and stage-specific outcomes of lifelong never-smokers with non-small cell lung cancer (NSCLC).
2007,
Pubmed
Tammemagi,
Smoking and lung cancer survival: the role of comorbidity and treatment.
2004,
Pubmed
Tasevska,
A prospective study of meat, cooking methods, meat mutagens, heme iron, and lung cancer risks.
2009,
Pubmed
Thun,
Lung cancer occurrence in never-smokers: an analysis of 13 cohorts and 22 cancer registry studies.
2008,
Pubmed
Toh,
Never-smokers with lung cancer: epidemiologic evidence of a distinct disease entity.
2006,
Pubmed
Wakelee,
Lung cancer incidence in never smokers.
2007,
Pubmed
Wong,
The EML4-ALK fusion gene is involved in various histologic types of lung cancers from nonsmokers with wild-type EGFR and KRAS.
2009,
Pubmed
,
Echinobase
Wu,
Previous lung disease and risk of lung cancer among lifetime nonsmoking women in the United States.
1995,
Pubmed
Yano,
Never-smoking nonsmall cell lung cancer as a separate entity: clinicopathologic features and survival.
2008,
Pubmed
Yong,
Intake of vitamins E, C, and A and risk of lung cancer. The NHANES I epidemiologic followup study. First National Health and Nutrition Examination Survey.
1997,
Pubmed
Yoon,
CYP1B1, CYP1A1, MPO, and GSTP1 polymorphisms and lung cancer risk in never-smoking Korean women.
2008,
Pubmed
Yoshino,
Smoking status as a prognostic factor in patients with stage I pulmonary adenocarcinoma.
2006,
Pubmed
Zeka,
Lung cancer and occupation in nonsmokers: a multicenter case-control study in Europe.
2006,
Pubmed
Zell,
Epidemiology of bronchioloalveolar carcinoma: improvement in survival after release of the 1999 WHO classification of lung tumors.
2005,
Pubmed
Zhong,
Exposure to environmental tobacco smoke and the risk of lung cancer: a meta-analysis.
2000,
Pubmed
de Perrot,
Sex differences in presentation, management, and prognosis of patients with non-small cell lung carcinoma.
2000,
Pubmed
